Nacco Industries Inc. (NC) Jumps 5.4% on February 12

Equities Staff |

Nacco Industries Inc. (NC) was among the biggest gainers on the Russell 2000 for Friday February 12 as the stock popped 5.4% to $47.20, representing a gain of $2.42 per share. Some 40,339 shares traded hands on 204 trades, compared with an average daily volume of 21,153 shares out of a total float of 6.83 million. The stock opened at $44.81 and traded with an intraday range of $48.45 to $44.72.

After today's gains, Nacco Industries Inc. reached a market cap of $322.52 million. Nacco Industries Inc. has had a trading range between $62.96 and $40.04 over the last year, and it had a 50-day SMA of $43.60 and a 200-day SMA of $50.18.

Nacco Industries Inc is a holding company, which through its subsidiaries, operate in mining, small appliances, and specialty retail businesses. Its segment includes NACoal, HBB and KC.

Nacco Industries Inc. is based out of Cleveland, OH and has some 4,000 employees. Its CEO is Alfred M. Rankin.

For a complete fundamental analysis analysis of Nacco Industries Inc., check out Equities.com’s Stock Valuation Analysis report for NC. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.